It is hoped the Medical Research Council award will help the scientists discover improved treatments for nicotine dependence - which can result in increased rates of illness and death from smoking-related diseases - as well as treatments for the symptoms of schizophrenia.
The funding will provide a three-year fellowship for Dr Ruth Barr, a psychiatrist in the School of Medicine and Dentistry.
Dr Barr hopes to build on research she has carried out during a fellowship at Harvard Medical School in Massachusetts on the effects of nicotine on attention and memory in schizophrenia.
The effects of nicotine withdrawal will be measured on around 40 volunteers, including both those with and without the condition.
Dr Barr said: “The reasons behind the increased need to smoke in patients with schizophrenia are unclear, although certain symptoms of this illness may increase vulnerability to nicotine dependence.
“Schizophrenia is associated with cognitive impairments – including deficits in inhibitory control which may make it more difficult for patients to resist the impulse to smoke.
“We propose to investigate the effects of nicotine and nicotine withdrawal in smokers with and without schizophrenia on response inhibition, measured using a computer task.
“Cognitive abilities are believed to get worse during nicotine withdrawal and we want to establish if this deterioration is greater in patients with schizophrenia.
“In addition, we will investigate the mechanism of nicotine’s effects on task performance using brain scanning and a measure of brain electrical activity.
“If we can understand why patients with schizophrenia are more likely to smoke it could enable us to develop new treatments for nicotine dependence and symptoms of schizophrenia.”
Dr Barr will be supervised by Professors Stephen Cooper and Professor Gavin Reynolds from the Division of Psychiatry and Neuroscience in the School of Medicine and Dentistry.
Lisa Mitchell | alfa
Success at leading conference on silicon materials science and technology in Japan
13.12.2018 | IHP - Leibniz-Institut für innovative Mikroelektronik
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy